Emerging roles for radiometabolic therapy of tumors based on auger electron emission

Journal of Nuclear Medicine

Volumn 41, Issue 9, 2000, Pages 1519-1521

  Mariani, G ^a   Bodei, L ^a   Adelstein, S J ^a   Kassis, A I ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HALOGEN; PENTETREOTIDE IN 111; RADIOISOTOPE; SOMATOSTATIN ANALOG;

CANCER THERAPY; DRUG EFFICACY; HUMAN; ISOTOPE LABELING; NEUROENDOCRINE TUMOR; NONHUMAN; NOTE; PRIORITY JOURNAL; RADIOBIOLOGY; RADIOCHEMISTRY; RADIOISOTOPE THERAPY;

CELL NUCLEUS; ELECTRONS; HUMAN; INDIUM RADIOISOTOPES; NEUROENDOCRINE TUMORS; OCTREOTIDE; RADIOPHARMACEUTICALS;

EID: 0033805981     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (33)

1. 1]-octreotide: A case history
2. 1-octreotide in midgut carcinoid syndrome
3. Somatostatin receptor: Scintigraphy and radionuclide therapy
4. 111In-pentetreotide: Initial observations and future directions
5. 1]-octreotide in patients with neuroendocrine tumors: Evaluation of therapeutic and toxic effects
6. The Auger electron dosimetry of indium-111 in mammalian cells in vitro
7. 1]-octreotide in patients with neuroendocrine tumors
8. 1-octreotide
9. 3H: Nuclear versus cytoplasmic radiation effects in murine L1210 leukaemia
10. 3HTdR
11. Lethality of Auger electrons from the decay of bromine-77 in the DNA of mammalian cells
12. 125IUdR in mammalian cells: Implications of localized energy deposition by Auger processes
13. Radiotoxicity of 5-[123I]iodo-2'-deoxyuridine in V79 cells: A comparison with 5-[125I]iodo-2'-deoxyuridine
14. Radiolabeled nucleoside analogs in cancer diagnosis and therapy
15. Preclinical animal studies with radiodeoxyuridine
16. 125I]metaiodobenzylguanidine
17. Malignant astrocytomas treated with iodine-125 labeled monoclonal antibody 425 against epidermal growth factor receptor: A phase II trial
18. Epidermal growth factor receptor 425 monoclonal antibodies radiolabeled with iodine-125 in the adjuvant treatment of high-grade astrocytomas
19. Internalization and nuclear localization of peptide hormones
20. 3]octreotide by mouse and human pituitary tumor cells: Increase by unlabeled octreotide
21. Internalisation of isotope-coupled somatostatin analogues
22. Multiply radioiodinated somatostatin analogs induce receptor-specific cytotoxicity
23. 111In-DTPA-octreotide in the same patients: Biodistribution, kinetics, organ and tumor uptake
24. Neuropeptide receptors in health and disease: The molecular basis for in vivo imaging
25. Immunohistochemical detection of somatostatin receptor subtypes sst1 and sst2A in human somatostatin receptor positive tumors
26. Yttrium-90-labelled somatostatin-analogue for cancer treatment
27. 3-octreotide: Preliminary report in cancer patients
28. Dosimetry of Auger emitters: Physical and phenomenological approaches
29. 3 derivatives of octreotide in rats
30. 3] octreotide as carriers for somatostatin receptor-targeted scintigraphy and radionuclide therapy
31. 3]octreotide: Peptides for somatostatin receptor-targeted scintigraphy and radionuclide therapy
32. Iodine-131 labelled octreotide: Not an option for somatostatin receptor therapy
33. Progressive nuclear translocation of somatostatin analogs